Navigation Links
Olympus Unveils New Dissolvable Post Sinus Surgery Products
Date:1/5/2012

CENTER VALLEY, Pa., Jan. 5, 2012 /PRNewswire/ -- Olympus, a precision technology leader in designing and delivering innovative solutions in Medical and Surgical Products, among other core businesses, today announced the addition of a broad line of advanced, dissolvable sinus spacing and hemostat products to its already extensive ENT product portfolio. These products include spacers, foams and powders available in either plant-based or chitosan polysaccharide polymers.

Through a distribution partnership with Hemostasis, LLC, the plant-based and chitosan compositions have been formulated to improve post sinus surgery recovery, comfort and healing. All products are biocompatible, dissolve naturally, require no mixing or special storage considerations and are easily conformed to fit nasal anatomy. Additionally, the sinus products minimize edema, bleeding and prevent post operative adhesions by maintaining space between the upper chambers of the nasal cavities.  

"The new offerings extend Olympus' current world-class ENT solutions to surgeons performing sinus and anterior skull base procedures and their patients," commented Perry Mykleby, Vice President of Marketing for Olympus' ENT sales. "We are pleased to collaborate with Hemostasis, a high-quality medical device manufacturer partner, to enhance patient care."

"Hemostasis is committed to providing the most comprehensive, technologically advanced ENT sinus spacing and hemostat technologies that are safe and effective for their intended use," said Hemostasis' President, Keith Roberts. "Working directly with leading physicians, we have developed practical technologies designed to optimize physician usability and efficacy, which ultimately have improved procedure outcomes and enhances overall patient care."

About Olympus Medical Systems ENT Business
Olympus develops procedure solutions for healthcare professionals that help improve outcomes and enhance quality of life for their patients. Our ENT Business offers advanced visualization and treatment products for Rhinology, Pediatric ENT, Laryngology, Otology, Sleep and Head and Neck procedures. Products include endoscopy and video; powered electrosurgical and manual instruments, middle ear prosthetics, and vent (PE) tubes.

For more information about Olympus America, visit www.olympusamerica.com.
For more information about ENT products, click here.

About Hemostasis, LLC
Hemostasis is a dynamic company committed to developing and marketing innovative technologies for the rapidly changing demands of the global medical industry. We work directly with leading physicians to develop practical products that are designed to optimize usability and efficacy for medical professionals, improve procedure outcomes and enhance overall patient care. www.hemostasisllc.com.


'/>"/>
SOURCE Olympus America
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Omnyx Licenses Olympus Digital Pathology Patents
2. Olympus America Licenses Digital Pathology Patents to BioImagene, Inc.
3. Olympus Launches 2011 National Innovation Awards Program
4. Stryker Announces Definitive Agreement to Sell OP-1 for Use in Orthopaedic Bone Applications to Olympus
5. Stryker Completes Sale of OP-1 for use in Orthopaedic Bone Applications to Olympus
6. Gumz to Retire as President and CEO of Olympus Corporation of the Americas
7. Olympus Biotech Names Oliver Burckhardt to President North America
8. Olympus Introduces Worlds First Autoclavable 5mm HD Deflectable Videolaparoscope
9. Olympus Introduces New Peracetic Acid Solution for Rapid High-Level Disinfection
10. Olympus Broadens Portfolio With a Suite of New Single-Use Aspiration Needles
11. Oregon Tourism Commission Unveils New Online Customer Service Training Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has announced ... Analysis 2016 - Forecast to 2022" report to their ... contains up to date financial data derived from varied research ... trends with potential impact on the market during the next ... which comprises of sub markets, regional and country level analysis. ...
(Date:6/23/2016)... , June 23, 2016 Research ... Pharma News Issue 52" report to their offering. ... in influenza treatment creates a favourable commercial environment for MedImmune ... growing patient base that will serve to drive considerable growth ... vaccine would serve to cap sales considerably, but development is ...
(Date:6/23/2016)... , June 23, 2016 , ... Thursday, July 7, 2016 , , , , LOCATION: , ... , , , , EXPERT PANELISTS:  , , , Frost ... Industry Analyst, Christi Bird; Senior Industry Analyst, Divyaa Ravishankar and Unmesh ... The global pharmaceutical industry is witnessing an exceptional era. Several ...
Breaking Medicine Technology:
(Date:6/27/2016)... Brooklyn, NY (PRWEB) , ... June 27, 2016 ... ... is using cutting edge technology to revolutionize the emergency ambulance transport experience for ... Many are aware of how Uber has disrupted the taxi industry through the ...
(Date:6/26/2016)... ... 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, a holistic ... World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility is located. ... some of the world’s leading providers of cereal and other breakfast foods. Its residents ...
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery ... of Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , ... for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey ...
(Date:6/25/2016)... TX (PRWEB) , ... June 25, 2016 , ... ... the United States, named Dr. Sesan Ogunleye, as the Medical Director of its new ... the facility Medical Director of our new Mesquite location,” said Dr. James M. Muzzarelli, ...
Breaking Medicine News(10 mins):